Cancer is classified as a complex and heterogeneous collection of disease with over 100 different types of cancer. Numerous medicinal plants have been reported to have anticancer effect and effort for finding new anticancer agents with better efficacy and lesser side effects is still going on. Due to increasing cost of drug development, there is an urgent need for innovative approaches for target identification and efficacy prediction to uncover the therapeutic effect of drugs. A network-based approach is expected to offer important insights into the relationship between plants based active products and anticancer targets. In recent times, a renewed interest in understanding metabocentric adaptation occurring in the cancer cells vis-à-vis inflammation, angiogenesis and metastasis has been observed. Given the functional interdependencies between anti-cancer molecular targets and phytochemicals, emerging tools of network medicine offer a platform to explore systematically complexity of cancer biology, drug targets and therapeutic use of phytochemicals. In the special issue we invite the researchers to contribute original and review articles regarding network-based drug discovery, anti-cancer molecular targets and therapeutic use of phytochemicals. 
